Market Insider

Early movers: AZN, TM, TSLA, RIG, F, WEN, Z & more

Traders work the floor of the New York Stock Exchange on the evening of January 23, 2014 in New York City.
Getty Images

Check out which companies are making headlines before the bell:

AstraZeneca–The drug maker's shares are higher amid new speculation that Pfizer is about to unveil an improved offer for its British rival worth about $113 billion.

Barclays—The bank is cutting 19,000 jobs over the next three years. It also announced it's setting up a so-called "bad bank" for a large chunk of its investment banking business.

Toyota–The auto giant is forecasting a 2.4 percent drop in profit for the current fiscal year, which would put the automaker's profit below analyst estimates. Toyota points to currency fluctuations, a factor that helped the company during the last fiscal year, when it reported record profit.

Priceline–The travel site operator earned $7.81 per share for the first quarter, excluding certain items, above estimates of $6.92, with CEO Darren Huston saying Priceline is seeing attractive growth in newer markets as well as improving in its established markets.–Amazon is expanding its Sunday package delivery service by another 15 cities.

Dish Network–The satellite TV operator reported first quarter profit of 38 cents per share, six cents below estimates. Revenue did beat expectations, but higher expenses impacted Dish's bottom line.

Regeneron Pharmaceuticals–The drug maker earned $2.26 per share for its first quarter, excluding certain items, six cents above estimates, with revenue strongly above consensus as well. Regeneron was helped by strong sales for its eye treatment Eylea.

WhiteWave Foods–The organic food producer earned 22 cents per share for the first quarter, two cents above estimates. Revenue of $830 million was well above consensus of $789 million, as sales of almond milk and coffee creamers helped improve overall results.

Wendy's–The restaurant chain earned seven cents per share, excluding certain items, for the first quarter, beating estimates by two cents. Revenue was well above estimates, with Wendy's benefiting from lower costs, as well as new product and mobile payment initiatives.

Keurig Green Mountain —The coffee pod producer earned $1.08 per share, excluding certain items, for its second quarter, beating estimates by 14 cents. Keurig is also expanding its partnership with J.M. Smucker, agreeing to make and sell pods for Smucker coffee brands like Folger.

Ford–The automaker announced a $1.8 billion stock buyback, in a move to offset share dilution stemming from the potential conversions of senior convertible notes coming due in November 2016.

AppleThe tech giant announced its North American sales chief Zane Rowe is leaving the company. He'll be replaced by Doug Beck, who is currently in charge of sales in Japan and Korea.

Tesla Motors—Tesla reported first quarter profit of 12 cents per share, excluding certain items, two cents above estimates, with revenue beating consensus as well. However, its second quarter outlook is somewhat weaker than many investors had been expecting.

SolarCity–SolarCity lost 82 cents per share for the first quarter, eight cents wider than expected, though revenue exceeded expectations. The maker of residential solar equipment also raised its full-year forecast.

Zillow–The real estate website operator surprised investors by posting a profit of two cents per share, excluding certain items, compared to expectations of an eight cent loss. Revenue beat forecasts on an increase in the number of paid users.

Sprouts Farmers Market–Sprouts beat estimates for the first quarter by three cents, with profit of 23 cents per share, excluding certain items. The specialty grocer also raised its full year forecast as sales grow faster than initially thought.

SanDisk —The company increased its quarterly dividend by 33 percent to 30 cents per share.

Transocean–Transocean topped estimates by 41 cents with first quarter profit of $1.43 per share excluding certain items. The offshore driller also beat on the top line, and was helped by a drop in expenses and taxes.

Gilead Sciences–The company announced a $5 billion stock buyback program. The drug maker's announcement comes with $2.9 billion still remaining on a prior repurchase authorization.

By CNBC's Peter Schacknow

Questions? Comments? Email us at